Nucor forecasts Q4 EPS decline, cites seasonal effects and margin compression
Nucor (NYSE:NUE) has provided its earnings guidance for the fourth quarter of fiscal year 2025, forecasting earnings per share (EPS) in the range of $1.65 to $1.75.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Nucor (NYSE:NUE) has provided its earnings guidance for the fourth quarter of fiscal year 2025, forecasting earnings per share (EPS) in the range of $1.65 to $1.75.
Jabil (NYSE:JBL) has reported preliminary, unaudited financial results for the first quarter of fiscal year 2026, posting strong performance with net revenue of $8.3 billion.
The company's U.S. GAAP operating income stood at $283 million, and U.S. GAAP diluted earnings per share (EPS) was $1.35.
Texas Pacific Land Corporation (NYSE:TPL) has announced a strategic partnership with Bolt Data & Energy (Bolt) to develop large-scale data center campuses and the necessary infrastructure across TPL land.
Warner Bros. Discovery (NASDAQ:WBD) has announced that its Board of Directors has unanimously rejected the tender offer launched by Paramount Skydance (NASDAQ:PSKY) on December 8, 2025.
ABM (NYSE:ABM) has announced its agreement to acquire WGNSTAR in a cash transaction valued at approximately $275 million.
Sealed Air (NYSE:SEE) announced the expiration of the 30-day go-shop period under its definitive merger agreement with funds affiliated with Clayton, Dubilier & Rice (CD&R) on December 16, 2025.
Merck (NYSE:MRK) announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy.
Pfizer (NYSE:PFE) and Astellas have announced positive topline results from the interim analysis of the Phase 3 EV-304 (KEYNOTE-B15) trial, evaluating the combination of PADCEV (enfortumab vedotin) and Keytruda (pembrolizumab) in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC).
Sinclair (NASDAQ:SBGI) issued a statement today in response to The E.W. Scripps Company (NASDAQ:SSP) rejecting its proposal for a potential merger.
Veru (NASDAQ:VERU) announced its fiscal 2025 results and provided updates on its clinical development of enobosarm for obesity treatment on December 17, 2025.
Wallbox (NYSE:WBX), a global leader in electric vehicle (EV) charging and energy management solutions, announced the appointment of Isabel López Trujillo as Chief Financial Officer (CFO), effective January 7, 2026.
Hut 8 (NASDAQ:HUT) has announced a strategic partnership with Anthropic and Fluidstack to build hyperscale AI data center infrastructure in the U.S., with an initial deployment of 245 MW at River Bend.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade